Changing the Paradigm of CMV Management in the HCT Setting

Changing the Paradigm of CMV Management in the HCT Setting

Journal Club | Letermovir for CMV prophylaxis in post-HCT CMV seropositive patientsПодробнее

Journal Club | Letermovir for CMV prophylaxis in post-HCT CMV seropositive patients

2023 Updates on CMV Management after TransplantПодробнее

2023 Updates on CMV Management after Transplant

ID Management of Heme Malignancies and SCTs -- Olga Klinkova and Aliyah BaluchПодробнее

ID Management of Heme Malignancies and SCTs -- Olga Klinkova and Aliyah Baluch

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic Cell TransplantationПодробнее

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic Cell Transplantation

Current and Future Treatment of CMV | Robin Avery, MDПодробнее

Current and Future Treatment of CMV | Robin Avery, MD

Cytomegalovirus infection in organ transplantation new strategies for an old problem - ESOT CongressПодробнее

Cytomegalovirus infection in organ transplantation new strategies for an old problem - ESOT Congress

Roy Chemaly: Cytomegalovirus and transplantПодробнее

Roy Chemaly: Cytomegalovirus and transplant

Imaging Object Change Management (IOCM)Подробнее

Imaging Object Change Management (IOCM)

Update on CMV and Treatment Options for 2022 -- Aliyah Baluch, MDПодробнее

Update on CMV and Treatment Options for 2022 -- Aliyah Baluch, MD

Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patientsПодробнее

Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients

Ongoing Research for CMV Management in HSCT PatientsПодробнее

Ongoing Research for CMV Management in HSCT Patients

Myth #5 - You need to be a configuration expert to manage configuration models.Подробнее

Myth #5 - You need to be a configuration expert to manage configuration models.

The Need for CMV Prophylaxis in the Transplant SettingПодробнее

The Need for CMV Prophylaxis in the Transplant Setting

Cytomegalovirus in solid organ transplant recipientsПодробнее

Cytomegalovirus in solid organ transplant recipients

Evaluating Letermovir in HCT PatientsПодробнее

Evaluating Letermovir in HCT Patients

Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipientsПодробнее

Predicting and diagnosing TB and CMV in hematopoietic cell transplant recipients

WBMT/ISBMT Webinar: Management of Viral Infections in Hematopoietic Stem-Cell Transplant - June 2022Подробнее

WBMT/ISBMT Webinar: Management of Viral Infections in Hematopoietic Stem-Cell Transplant - June 2022

Update on Initial Management of Advanced HCCПодробнее

Update on Initial Management of Advanced HCC

Популярное